Skip to main content
. 2010 Apr;23(2):169–180. doi: 10.1089/vim.2009.0099

Table 1.

I-Ab and I-As Restricted Epitopes

I-Ab restricted epitopes Spots per 106 T cells ± SE (n) I-As restricted epitopes Spots per 106 T cells ± SE (n)
HA 16: 90 KESWSYIVETPNPENGT 106 100 23 (13) HA 21: 120 EQLSSVSSFERFEIFPK 136 306 53 (10)
HA 35: 203 NQRALYHTENAYVSVVS 219 119 14 (25) HA 22: 126 SSFERFEIFPKESSWPN 142 663 66 (16)
HA 52: 304 SSLPFQNVHPVTIGECP 320 93 29 (5) HA 23: 132 EIFPKESSWPNHTVTGV 148 300 48 (10)
HA 53: 310 NVHPVTIGECPKYVRSA 326 56 21 (3) HA 24: 138 SSWPNHTVTGVSASCSH 154 91 19 (10)
NA 19: 108 IGSKGDVFVIREPFIS 123 34 5 (5) HA 25: 144 TVTGVSASCSHNGKSSF 160 426 48 (14)
NA 20: 113 DVFVIREPFISCSHLE 128 134 19 (17) HA 28: 162 RNLLWLTGKNGLYPNLS 178 263 40 (10)
NA 30: 171 NSKFESVAWSASACHDG 187 168 31 (10) HA 38: 221 HYSRRFTPEIAKRPKVR 237 84 13 (10)
NA 31: 177 VAWSASACHDGMGWLTI 193 195 46 (10) HA 53: 310 NVHPVTIGECPKYVRSA 326 123 25 (10)
NA 47: 273 NFHYEECSCYPDTGTVM 289 174 25 (19) HA 54: 316 IGECPKYVRSAKLRMVT 332 191 46 (10)
NA 56: 327 RPKDGEGSCNPVTVDGA 343 86 33 (4) HA 55: 322 YVRSAKLRMVTGLRNIP 338 93 20 (10)
NA 76: 446 FCGVNSDTANWSWPDGA 462 61 12 (3) HA 57: 334 LRNIPSIQSRGLFGAIA 350 243 40 (10)
NA 77: 452 DTANWSWPDGAELPFTI 468 170 30 (13) HA 65: 380 DQKSTQNAINGITNKVN 396 61 8 (10)
NP 25: 145 DTTYQRTRALVRTGMDP 161 56 18 (2) HA 66: 386 NAINGITNKVNSVIEKM 402 428 60 (14)
NP 44: 258 FLARSALILRGSVAHKS 274 381 41 (10) NA 45: 261 GKVTKSIELNAPNFHYE 277 161 23 (15)
NP 45: 264 LILRGSVAHKSCLPACV 280 418 54 (10) NA 47: 273 NFHYEECSCYPDTGTVM 289 272 54 (4)
NP 46: 270 VAHKSCLPACVYGPAVA 286 33 13 (5) NA 49: 285 TGTVMCVCRDNWHGSNR 301 55 35 (4)
NP 47: 276 LPACVYGPAVASGYDFE 292 157 15 (20) NA 61: 357 VWIGRTKSNRLRKGFEM 373 112 19 (9)
NP 48: 282 GPAVASGYDFEKEGYSL 298 53 17 (7) NP 4: 19 RQNATEIRASVGRMIGG 35 57 25 (6)
NP 52: 306 LLQTSQVYSLIRPNENP 322 848 106 (16) NP 16: 91 KTGGPIYKRVDGKWVRE 107 230 45 (10)
NP 53: 312 VYSLIRPNENPAHKSQL 328 438 66 (10) NP 17: 97 YKRVDGKWVRELVLYDK 113 403 61 (14)
NP 71: 420 FDKTTIMAAFTGNTEGR 436 39 16 (4) NP 45: 264 LILRGSVAHKSCLPACV 280 208 49 (4)
M1 2: 7 VETYVLSIVPSGPLKAE 23 66 11 (7) NP 46: 270 VAHKSCLPACVYGPAVA 286 1139 130 (17)
M1 3: 13 SIVPSGPLKAEIAQRLE 29 65 12 (12) NP 47: 276 LPACVYGPAVASGYDFE 292 33 9 (8)
M1 24: 139 TTESAFGLICATCEQIA 155 55 20 (6) NP 55: 324 HKSQLVWMACNSAAFED 340 38 8 (8)
NS1 13: 72 ESDEAFKMTMASALASR 88 71 17 (12) NP 58: 342 RVSSFIRGTRVLPRGKL 358 220 41 (10)
NS1 14: 78 KMTMASALASRYLTDMT 94 63 12 (13) NP 74: 438 SDMRAEIIKMMESARPE 454 217 37 (10)
NS1 19: 108 KQKVAGPLCVRMDQAIM 124 91 14 (21) NP 75: 444 IIKMMESARPEEVSFQG 460 224 31 (14)
NS1 31: 180 VLIGGLEWNDNTVRVSE 196 62 9 (14) M1 18: 103 LKREITFHGAKEIALSY 119 63 11 (10)
      M1 31: 181 LASTTAKAMEQMAGSSE 197 208 19 (10)
      M1 36: 210 RQMVQAMRAIGTHPSSS 226 157 18 (7)
      NS1 10: 54 IETATCVGKQIVERILK 70 144 16 (2)

Summary of CD4 peptide epitopes identified in C57BL/10 mice (left) and in SJL mice (right) in response to primary influenza infection. Indicated for each peptide epitope are the average spot count per million CD4 T cells, the standard error (SE), and the number of experiments in which the peptide was tested (n). Major epitopes are indicated in bold. Underlined residues represent the core epitope as determined by use of truncated peptides (not shown).